Toward quality assessment of 3D printed oral dosage forms

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Toward quality assessment of 3D printed oral dosage forms. / Markl, Daniel; Zeitler, Axel; Rades, Thomas; Rantanen, Jukka; Bøtker, Johan.

In: Journal of 3D Printing in Medicine, Vol. 2, No. 1, 15.12.2017, p. 27-33.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Markl, D, Zeitler, A, Rades, T, Rantanen, J & Bøtker, J 2017, 'Toward quality assessment of 3D printed oral dosage forms', Journal of 3D Printing in Medicine, vol. 2, no. 1, pp. 27-33. https://doi.org/10.2217/3dp-2017-0016

APA

Markl, D., Zeitler, A., Rades, T., Rantanen, J., & Bøtker, J. (2017). Toward quality assessment of 3D printed oral dosage forms. Journal of 3D Printing in Medicine, 2(1), 27-33. https://doi.org/10.2217/3dp-2017-0016

Vancouver

Markl D, Zeitler A, Rades T, Rantanen J, Bøtker J. Toward quality assessment of 3D printed oral dosage forms. Journal of 3D Printing in Medicine. 2017 Dec 15;2(1):27-33. https://doi.org/10.2217/3dp-2017-0016

Author

Markl, Daniel ; Zeitler, Axel ; Rades, Thomas ; Rantanen, Jukka ; Bøtker, Johan. / Toward quality assessment of 3D printed oral dosage forms. In: Journal of 3D Printing in Medicine. 2017 ; Vol. 2, No. 1. pp. 27-33.

Bibtex

@article{42e6440496b649e699af484744b32695,
title = "Toward quality assessment of 3D printed oral dosage forms",
abstract = "The additive manufacturing industry achieved a corporate annual growth rate of 25.9{\%} according to the Forbes analysis of the Wohlers Report 2016. This high growth rate is placed in perspective when looking at the past 27 years where the corporate annual growth rate has averaged 26.2{\%} each year indicating that additive manufacturing is clearly a growing industry. Such growth needs to be supported by suitable quality testing methods: with the economic success achieved in this market and the associated transition from mass production toward mass customization comes the need for new and innovative methods to assess the quality of the 3D printed geometries. This will be especially important for pharmaceutical products where a sub-standard quality of the final product can have detrimental consequences for patient health and safety.",
author = "Daniel Markl and Axel Zeitler and Thomas Rades and Jukka Rantanen and Johan B{\o}tker",
note = "doi: 10.2217/3dp-2017-0016",
year = "2017",
month = "12",
day = "15",
doi = "10.2217/3dp-2017-0016",
language = "Dansk",
volume = "2",
pages = "27--33",
journal = "Journal of 3 D Printing in Medicine",
issn = "2059-4755",
publisher = "Future Science",
number = "1",

}

RIS

TY - JOUR

T1 - Toward quality assessment of 3D printed oral dosage forms

AU - Markl, Daniel

AU - Zeitler, Axel

AU - Rades, Thomas

AU - Rantanen, Jukka

AU - Bøtker, Johan

N1 - doi: 10.2217/3dp-2017-0016

PY - 2017/12/15

Y1 - 2017/12/15

N2 - The additive manufacturing industry achieved a corporate annual growth rate of 25.9% according to the Forbes analysis of the Wohlers Report 2016. This high growth rate is placed in perspective when looking at the past 27 years where the corporate annual growth rate has averaged 26.2% each year indicating that additive manufacturing is clearly a growing industry. Such growth needs to be supported by suitable quality testing methods: with the economic success achieved in this market and the associated transition from mass production toward mass customization comes the need for new and innovative methods to assess the quality of the 3D printed geometries. This will be especially important for pharmaceutical products where a sub-standard quality of the final product can have detrimental consequences for patient health and safety.

AB - The additive manufacturing industry achieved a corporate annual growth rate of 25.9% according to the Forbes analysis of the Wohlers Report 2016. This high growth rate is placed in perspective when looking at the past 27 years where the corporate annual growth rate has averaged 26.2% each year indicating that additive manufacturing is clearly a growing industry. Such growth needs to be supported by suitable quality testing methods: with the economic success achieved in this market and the associated transition from mass production toward mass customization comes the need for new and innovative methods to assess the quality of the 3D printed geometries. This will be especially important for pharmaceutical products where a sub-standard quality of the final product can have detrimental consequences for patient health and safety.

U2 - 10.2217/3dp-2017-0016

DO - 10.2217/3dp-2017-0016

M3 - Tidsskriftartikel

VL - 2

SP - 27

EP - 33

JO - Journal of 3 D Printing in Medicine

JF - Journal of 3 D Printing in Medicine

SN - 2059-4755

IS - 1

ER -

ID: 189765191